Dendritic Cell Vaccination in Patients With Advanced Melanoma
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate a method of using dendritic cells (a kind of
white blood cell) as a vaccine to stimulate your own immune system to react to your melanoma
cells.